These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8623257)

  • 41. The footprint of antibody bound to pig cells: evidence of complex surface topology.
    Everett ML; Lin SS; Worrell SS; Platt JL; Parker W
    Biochem Biophys Res Commun; 2003 Feb; 301(3):751-7. PubMed ID: 12565844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful down-regulation of natural and xenoreactive antibodies in pig-to-baboon xenotransplantation by high-dose cyclophosphamide.
    Morschheuser T; Steinhoff G; Indzhiia L; Heiser A; Hein M; Lapin BA; Haverich A
    Transplant Proc; 1997; 29(1-2):970-2. PubMed ID: 9123612
    [No Abstract]   [Full Text] [Related]  

  • 43. Cytotoxic effects of human preformed anti-Gal IgG and complement on cultured pig cells.
    Koren E; Kujundzic M; Koscec M; Neethling FA; Richards SV; Ye Y; Zuhdi N; Cooper DK
    Transplant Proc; 1994 Jun; 26(3):1336-9. PubMed ID: 8029931
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterization of anti-Gal antibody-producing cells of baboons and humans.
    Xu Y; Yang YG; Ohdan H; Ryan D; Harper D; Wu C; Kruger-Grey HS; Thall AD; Awwad M; Sykes M
    Transplantation; 2006 Mar; 81(6):940-8. PubMed ID: 16570021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study of the xenoantigenicity of adult pig islets cells.
    Komoda H; Miyagawa S; Kubo T; Kitano E; Kitamura H; Omori T; Ito T; Matsuda H; Shirakura R
    Xenotransplantation; 2004 May; 11(3):237-46. PubMed ID: 15099203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies.
    Parker W; Lundberg-Swanson K; Holzknecht ZE; Lateef J; Washburn SA; Braedehoeft SJ; Platt JL
    Hum Immunol; 1996 Feb; 45(2):94-104. PubMed ID: 8882406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of alpha 1,3-galactosyltransferase knockout mice.
    Tange M; Tearle R; Katerelos M; Crawford R; Robins A; Shinkel T; Pearse M; d'Apice AJ
    Transplant Proc; 1996 Apr; 28(2):620-1. PubMed ID: 8623306
    [No Abstract]   [Full Text] [Related]  

  • 48. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
    Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
    Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potent inhibition of human and baboon anti-alpha Gal antibodies by a subfraction of oligosaccharides derived from porcine stomach mucin.
    Li S; Neethling FA; Yeh JC; Cooper DK; Cummings RD
    Transplant Proc; 1996 Apr; 28(2):558. PubMed ID: 8623268
    [No Abstract]   [Full Text] [Related]  

  • 50. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
    Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
    Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specificity and function of "natural" antibodies in immunodeficient subjects: clues to B cell lineage and development.
    Parker W; Yu PB; Holzknecht ZE; Lundberg K; Buckley RH; Platt JL
    J Clin Immunol; 1997 Jul; 17(4):311-21. PubMed ID: 9258770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical potential of xenotransplantation.
    Cooper DK; Koren E; Oriol R
    Transplant Proc; 1994 Jun; 26(3):1331-2. PubMed ID: 7518129
    [No Abstract]   [Full Text] [Related]  

  • 53. Identification and characterization of a galactosyl peptide mimetic. Implications for use in removing xenoreactive anti-A Gal antibodies.
    Kooyman DL; McClellan SB; Parker W; Avissar PL; Velardo MA; Platt JL; Logan JS
    Transplantation; 1996 Mar; 61(6):851-5. PubMed ID: 8623148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-related development of human anti-pig xenoantibody.
    Xu H; Edwards N; Chen JM; Dong X; Michler RE
    J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1023-9. PubMed ID: 7475130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant Galalpha1,3Gal-substituted mucin/immunoglobulin chimeras: a superior absorber of anti-pig antibodies.
    Liu J; Holgersson J
    Transplant Proc; 2000 Aug; 32(5):859. PubMed ID: 10936244
    [No Abstract]   [Full Text] [Related]  

  • 56. Natural anti-Gal antibodies prevent, rather than cause, autoimmunity in human Chagas' disease.
    Gazzinelli RT
    Res Immunol; 1991 Feb; 142(2):164-7. PubMed ID: 1907755
    [No Abstract]   [Full Text] [Related]  

  • 57. Heterogeneity of preformed human antipig xenogeneic antibodies.
    Koren E; Neethling FA; Ye Y; Niekrasz M; Baker J; Martin M; Zuhdi N; Cooper DK
    Transplant Proc; 1992 Apr; 24(2):598-601. PubMed ID: 1566446
    [No Abstract]   [Full Text] [Related]  

  • 58. Early induction of TIMP-1 in endothelial cells in response to human xenoreactive IgG.
    Boulday G; Coupel S; Coulon F; Soulillou J; Charreau B
    Transplant Proc; 2001; 33(1-2):701-2. PubMed ID: 11267026
    [No Abstract]   [Full Text] [Related]  

  • 59. Two genetic approaches to the galactose alpha 1,3 galactose xenoantigen.
    d'Apice AJ; Tange MJ; Chen GC; Cowan PJ; Shinkel TA; Pearse MJ
    Transplant Proc; 1996 Apr; 28(2):540. PubMed ID: 8623255
    [No Abstract]   [Full Text] [Related]  

  • 60. [LY-1+B lymphocytes and the secretion of autoantibodies].
    Cong YZ
    Sheng Li Ke Xue Jin Zhan; 1993 Jan; 24(1):73-5. PubMed ID: 7687381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.